1. Highlights of prescribing information Micardis ... - food and drug ... (n.d.-a). https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020850s032lbl.pdf
2. Hetero Labs Limited. U.S. Food & Drug Administration. [Revised in August 2015] https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205901Orig1s000lbl.pdf
3. KD. Tripathi. Drugs Affecting Renin-Angiotensin System. Essentials of medical pharmacology. Eighth edition. 2019. Page – 535-538.
4. A Prem Kumar, Anirudra Ghorai, Vasudev Kriplani, Rabindra Kumar Dash, J Aravinda, Paramesh Shamanna, TK Sabeer, Abdul Hannan, and Santosh Revankar. Clinical data analysis of telmisartan for hypertension management in Indian population. NIH National Library of Medicine, National centre for biotechnology information. PubMed Central June 2021. [Accessed on 7th May 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819792/
5. Philippe Gosse. A Review of Telmisartan in the Treatment of Hypertension: Blood Pressure Control in the Early Morning Hours. NIH National Library of Medicine, National centre for biotechnology information. PubMed Central. September 2006. [Accessed on 7th May 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993985/
6. Accord Healthcare Ireland Limited. Health Products Regulatory Authority (HPRA). [Revised in July 2021] http://www.hpra.ie/img/uploaded/swedocuments/8c0fc811-cf88-4bd5-818e-609e07fe1190.pdf